Recombinant Human Macrophage Colony-Stimulating Factor Reduces Plasma Cholesterol and Carrageenan Granuloma Foam Cell Formation in Watanabe Heritable Hyperlipidemic Rabbits

    loading  Checking for direct PDF access through Ovid


Abstract Previous studies have demonstrated that shortterm administration of recombinant human macrophage colony- stimulating factor (rhM-CSF) reduces plasma cholesterol in rabbits, nonhuman primates, and human subjects. This study extended the dose schedule of rhM-CSF to 8 weeks of continuous intravenous infusion (CIVI) in the Watanabe heritable hyperlipidemic (WHHL) rabbit and expanded the scope to include an assessment of macrophage-derivcd foam cell development. Ten male WHHL rabbits were injected subcutaneously with 1% carrageenan to promote formation of a macrophage-rich foam cell granuloma.Rabbits were infused with either vehicle or rhM-CSF at 100 μg/kg per day (weeks 1 through 5) followed by 300 /μg/kg per day (weeks 6 through 8). rhM-CSF (100 fig/kg per day) decreased total plasma cholesterol by 45% at 2 weeks compared with controls. The gradual return of plasma cholesterol toward control concentrations over the subsequent 3 weeks correlated with the appearance of circulating antibodies specific to rhM-CSF. Granuloma weights at harvest (8 weeks after infusion) were significantly lower (2.8±0.7 g, mean±SEM) in rhM-CSF-treated rabbits relative to controls (7.1±1.5 g, p<.05). Granulomas from rabbits treated with rhM-CSF contained lower concentrations of cholesterol (2.0+0.7 versus 6.1 ±1.5 fig/mg, F<.03) and cholesteryl ester (0.7±0.4 versus 3.9±1.2 figlmg, p<.03) than controls. Histological evaluation revealed that granulomas from the rhM-CSF-treated rabbits were more fibrous and contained fewer foam cells than those from controls. Immunohistochemical localization of endogenous macrophage colony- stimulating factor (M-CSF) in granuloma tissue from vehicle- treated rabbits revealed a diffuse, faint staining pattern. Granuloma tissue from rhM-CSF-treated rabbits exhibited staining for M-CSF that was more intense than in tissue from control rabbits. This study showed that the CIVI of rhM-CSF produced a significant reduction in plasma cholesterol and granuloma foam cell formation in WHHL rabbits. The increase in immunoreactive M-CSF in granulomas from rhMCSF- treated rabbits suggested that M-CSF may have enhanced the viability of macrophages and modulated their function in a manner that stimulated the processing of cholesterol and its mobilization from the granuloma.

Related Topics

    loading  Loading Related Articles